AMBEV S.A. current report, Q1 FY2026

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the period from March 1, 2026, to March 31, 2026. The report details consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council, in compliance with Article 11 of CVM Instruction # 44/2021. The filing was signed on April 10, 2026.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of insider trading activity and does not contain financial performance statements.

Group Transaction Type Net Share Change Notable Activity
Board of Directors Restricted Share Delivery +298,839 Acquired 298,839 shares at R$15.29 (Volume: R$4.57M).
Management Restricted Shares & Options +1,073,825 (Gross) Acquired 606,656 restricted shares and exercised 466,169 options. Renounced 667,633 shares.
Management Market Sales -380,000 (Approx.) Multiple sales via BTG Corretora and XP Corretora between R$14.50 and R$15.14.
Fiscal Council None 0 No transactions reported.

Material Changes

The filing does not provide comparative data against a prior period to determine material changes in financial performance. The only reported changes are in the shareholdings of insiders:

  • Board of Directors: Increased common share holdings from 30,400,903 to 30,699,742.
  • Management: Increased common share holdings from 4,585,877 to 4,753,962, despite significant selling activity offset by restricted share deliveries and option exercises.
  • Fiscal Council: Holdings remained static at 2,500 shares.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of specific securities transactions.

Investor Verification Checklist

  • Insider Selling Pressure: Verify the net impact of Management sales (approx. 380k shares sold) versus acquisitions (approx. 1.07M shares acquired via grants/options) to assess net insider sentiment.
  • Transaction Pricing: Note the spread in transaction prices for Management sales, ranging from R$14.50 to R$15.14, compared to the restricted share delivery price of R$15.29.
  • Option Exercise Costs: Confirm the cost basis for the 466,169 stock options exercised by Management at R$16.35, which is higher than the prevailing market sale prices.
  • Regulatory Compliance: Ensure all transactions align with the specific requirements of CVM Instruction # 44/2021 as cited in the filing.